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Abstract
This review article discusses Melinda Cooper and Catherine Waldby’s recent book,
Clinical Labor. Tissue donors and research subjects in the global bio-economy
(Duke, 2014), as a topical contribution to the literatures on the bio-economy, and to
studies of life sciences, society, and policy more generally. The article contextualizes
the book within existing literatures (1) and thoroughly considers its conceptual
approach as well as its findings (2). Further, it discusses its value as a contribution,
arguing that clinical labor also presents an intriguing framework for further research,
thereby suggesting some possible directions (3).
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Bio-economic aspirations and clinical labor
Roughly the last decade has seen the growing interest in a new object of social science
inquiry and socio-political imaginary, the “bio-economy”. As imaginary, the bio-economy
is perhaps best captured by the OECD’s aspiration to “turn the disruptive potential of bio-
technology to economic advantage“ (OECD 2009: 7). The bioeconomy has become a
matter of topical concern and a target of various policy programs, strategy papers and
public-private initiatives. Framed as a solution to a series of crises linked to problems of
poor productivity, declining profits, and an ever-growing appetite for innovation, the
bioeconomy has come to signify a crucial transformation in today’s knowledge-based
economies (Scharper-Rinkel 2012). Policy makers and stakeholders puzzle about how the
life sciences are to be successfully commercialized, what kinds of legal and technical in-
frastructures need to be put in place, and what kinds of specialized labor force needs to
be created to bring about a thriving bioeconomy (Hilgartner 2007).
Accordingly, the bioeconomy has also captured the interest of the social sciences. Soci-
ologists, anthropologists and STS scholars, among others, have started to explore the en-
tanglements between life sciences and political economy (see Helmreich 2008 for an
overview), centering on questions such as: How is value attached to newly emerging life
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forms, such as patented microbes or stem cells? How, and to which extent, are markets
created for entities hitherto excluded from market relations, such as human tissues and
body parts? How do these “tissue economies” (Mitchell and Waldby 2008) play out in glo-
bally refracted networks? In which ways do these novel articulations of knowledge and
value impact on social relationships, identities, and forms of subjectivity? (Thacker 2005,
Sunder Rajan 2006, 2012; Cooper 2008; Birch 2012; Dussauge et al. 2015)
In this body of work, the bio-economy signifies more than simply a new branch or
market segment (Lettow 2012), that is to say, an “economy of the life sciences” and its
frictionless commercialization of biomedical knowledge and productivity. For instance,
some contributions have suggested to explore a “biotechnological mode of production”
corresponding with the emergence of a “post-Fordist” political economy (Thompson
2005; Cooper 2008). Post-Fordism typically refers to a post-industrial regime of capital-
ist relations characterized by the rise of the service sector, increased financialization
and a “knowledge-based” type of valorization through the creative industries – but
equally by “new modes of biomedical production focused on innovation value and
newly defined contractual rights in the body” (Cooper & Waldby 2014: 3).
Other contributions argue that the bioeconomy amounts to a political epistemology:
a new mode of ordering socio-technical relations, regimes of truth, and systems of
values (Sunder Rajan 2006, 2012; Larsen 2007; Cooper 2008).
Melinda Cooper and Catherine Waldby’s book contributes to this scholarship by
zeroing in on the question of labor. In the policy discourses of the bioeconomy, the no-
tion of labor predominantly refers to the cognitive and technical skills of the knowledge
worker (researcher, engineer, project coordinator, etc.). This narrow focus silences the
role of a broad range of other subjects performing “clinical labor”, thereby significantly
contributing to biomedical innovation and bioeconomic generation of value.
Against this background, the authors suggest that despite the abundance of reflec-
tions on the bioeconomy in academic and policy discourse, “few have explored the very
material ways in which the in vivo biology of human subjects is enrolled into the post-
Fordist labor process” (Cooper & Waldby 2014: 7). Zeroing in on central forms and
practices of contemporary biomedicine (such as reproductive medicine and the clinical
trials industry), Cooper and Waldby thus explore clinical labor as a set of largely un-
acknowledged productive relations and account for its rise and saliency.
A cartography of global clinical labor
Clinical Labor is divided into three main parts. The first part introduces the analytical
perspective in theoretical and historical regard. Conceptually, the term “clinical labor”
facilitates a double critique. On the one hand it serves to assemble and articulate vari-
ous productive activities that tend to be dealt with separately: the participation in clin-
ical research trials, the donation of bodily materials and tissue samples for research or
for reproductive purposes, the carrying out of gestational surrogacy, the sharing of
valuable bio-information. Research subjects and tissue donors constitute the “clinical
laborers” of the global bio-economies, as they all perform “services in the self”: risky,
embodied forms of labor critical to the overall bio-economic enterprise. On the other
hand, the concept of clinical labor brushes conventional theories of labor, bioethics and
innovation against the grain: insofar as these theories ignore or actively exclude such
embodied work from the realm of formal labor, they fail to conceptualize and thus
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come to terms with clinical labor, analytically and theoretically, as a crucial set of social
productive forces.
The first chapter establishes “clinical labor” as a novel concept and traces its emer-
gence through a genealogy of tentative articulations of life, labor and value – including
Marx’s value theory of labor, Chicago school economics, and Italian post-operaismo.
Further, Cooper and Waldby elaborate crucial omissions and silences in the academic
as well as political and policy discourses, which, in a way, have circumnavigated the
question of clinical labor altogether. These silences prominently include bioethics to
the extent that bioethics has sought to protect subjects of biomedicine precisely by
shielding them from the spheres of market forces and paid wage-labor (p. 7–8). Chap-
ter 2 shows how the post-Fordist business model has redefined the relationships of
labor, risk and social reproduction. Precipitated by various currents, including the rise
of human capital theory, processes of de-unionization and heavy recourse to legal con-
tractualism, the independent contractor, “emblematic of precarious” as well as highly
risky labor, has emerged as salient figure of post-Fordist economies (p. 27).
In the global bioeconomy, independent contractors are contractors of their ‘biological
capital’ […], obliged to assume both the economic and corporeal risks of the biomedical
innovation economy.” (p. 27–28). Discriminating between the speculative risks of
innovation assumed by scientists and investors and the “visceral risks” of the clinical la-
borer, the bioeconomy in turn “depends on the devolution of uninsurable, embodied
risks to the clinical laborer” (p. 32). Moreover, these embodied risks are distributed un-
evenly within societies and across the globe, capitalizing on asymmetries and hierarch-
ies within and across categories of class, gender, and ethnicity. Perhaps unsurprisingly,
the economic precariat of deindustrialization, women, and ethnic minorities assume
the predominant share of the embodied risks of biomedical innovation. This is the case,
as subsequent chapters detail, because for those many “freed” from social security and
workplace insurance of the declining welfare state, clinical labor provides a necessary
source of subsistence, creating income opportunities for the unemployed and working
poor populations in their capacity as experimental or reproductive bodies in a global
service economy (p. 81).
Defined broadly as the worker’s assumption of biopolitical risks (p.18), clinical labor
it is nevertheless a historically specific concept that emerges against the background of
post-Fordism. Clearly, individuals and entire groups have been systematically exploited
for medical research from the 19th century onwards. Historically, prototypical clinical
labor has been tried and tested in secluded spaces institutionally separated from the
political economy proper and from formal labor relations (such as the prison, the asy-
lum, or the nuclear family). However, with the disintegration of “Fordist” productive re-
lations – including the denationalization of production, de-unionization of labor and
the de-differentiation of spheres of production, reproduction, and consumption – clin-
ical labor has become a ubiquitous form of informal, contractual labor heavily entwined
with neoliberal globalization, its social and economic restructuration, and its specific
modes of appropriation and exploitation.
Hence, the remainder of the book investigates how the biomedical industries draw
on, actively exploit, and (re-)produce the stratified social relations in a global post-
Fordist bioeconomy. In doing so it jointly explores the (bio-)technical and legal precon-
ditions that have enabled the rise of clinical labor as a global phenomenon.
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From reproductive to regenerative labor
The second and third part of the book engage empirically with two distinct, though re-
lated fields of the life sciences. Part II zeros in on reproductive biology, a sphere that
has for long been excluded, ideologically and legally, from the sphere of market rela-
tions. Yet, while reproductive labor as typically feminized work is deeply rooted in the
convoluted histories of class struggle, colonialism and sexual relations of domination,
“today the labor of human reproductive biology has become precisely a form of eco-
nomic labor in certain key sectors of the bioeconomy.” (p. 33). Chapter 3 explores arti-
ficial reproductive technologies (ART) and how their emergence in the US has enabled
the disentanglement of certain body parts such as oocytes from the body proper. Blur-
ring the boundaries of social and biological reproduction, ART manages to reorganize cer-
tain reproductive processes – such as fertilization or the entire gestation process qua
surrogacy – as services in the self that can be sourced out to "free and independent" con-
tractors. In that, ART has not only technologically altered biological reproduction, but
moreover has given rise to family relations beyond the conventional norms of kinship.
Yet, these shifts were possible only through the simultaneity of technological advances
and the socio-legal and economic realignment of reproduction on a global scale. Chapter
4 explores the ways these novel technologies have spread from the US to various other
countries worldwide, including detailed reports on Eastern European countries, Spain,
and India. It shows how the uptake and selective organization of ART in respective coun-
tries is related to the country’s position in the globally stratified biopolitical economy. A
newly emerging “fertility tourism” characterizes global biopolitical relations, and “repro-
ductive outsourcing is profoundly intertwined with the post-Fordist reorganization of
other kinds of feminized labors and the rendering of formally domestic, privatized aspects
of household reproduction as service labor, itself often transnationalized” (p. 87). Finally,
Chapter 5 traces a relocation of feminized bioeconomic tasks from ART and reproductive
labor to stem cell technologies and their corresponding form of regenerative labor. As a
thriving branch of the bioeconomy, stem cell research largely depends on cells and tissue
donated for research, among them IVF embryos, aborted fetuses or cord blood. In most
cases, women are conceptualized as voluntary participants and altruistic donors, even
though these “donations” involve considerable risks and efforts. Moreover, the material
practice of giving regenerative tissue to research simultaneously performs a transaction of
yet another kind: typically, the women-donor thereby transfers nonreversible ownership
rights to the recipient, be it a team of scientists or a biotech company, thereby receding
from all claims including future profits gained through biotechnological manipulation and
commercialization of disentangled cells and tissues.
Experimental labor
Part III explores experimental clinical labor done by human research subjects and pa-
tients in pharmaceutical clinical trials. Today’s ever growing drug consumption involves
growing markets in clinical trials, and thus the need for more clinical research subjects.
While the global search for subjects has become a pressing organizational and ethical
problem, clinical trial participation has largely remained to be considered as a voluntary
contribution to research and thus excluded from the realm of labor. That notwithstanding,
a multitude of subjects are motivated by financial “compensation” or even “undertake
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clinical trials as a form of paid work or work for health care” (p. 117), particularly in con-
texts where access to medical checks and basic health care is scarce or simply unavailable.
Cooper and Waldby begin by reconstructing the history of human subject research in
post-war America. Chapter 6 shows how clinical trials have moved from wartime excep-
tionalism into the secluded space of the carceral system. Later, as prison-based experiments
came under considerable critique, clinical research was moved into private medical centers
and contract research organizations. The growth of the clinical trials industries
notwithstanding, experimental labor has been kept away from the sphere of official
labor relations – and bioethics has been a major force in maintaining this legal
and discursive separation. From the 1990s onwards, newly liberalized countries
and emerging economies have provided new experimental spaces for offshoring
pharmaceutical production and clinical labor (Chapter 7). In a sense, the crisis of
pharmaceutical research was partially resolved by “contracting out” experimental
labor (and its embodied experimental risks) both institutionally and nationally.
Finally, the last chapter turns to a set of novel strategies and relations in drug
innovation that walk hand in hand with a realignment of the clinic and its central place
in the pharmaceutical business model. These strategies consist in opening up the con-
fined clinical-experimental space towards a more distributed form of public experi-
ment. On the one hand, patient groups in the US and elsewhere have increasingly
claimed a right to assume experimental risks by accessing investigational drug prod-
ucts. In this effort, some have formed alliances with pharmaceutical companies, or
enjoy the support of libertarian think tanks and their deregulatory agendas. On the
other hand, novel, mostly web-based strategies have sought to enroll the public in a
collective effort of data generation facilitating some sort of open source model of bio-
pharmaceutical innovation. Patients are asked to share and meticulously document
their experiences with medication regimes, thus collecting tons of “post-marketing”
data valuable to the pharmaceutical industry. Thereby the public is being reconfigured
as an “unwaged, highly skilled labor market” (p. 218), further blurring the lines between
clinic, market and society.
Discussion: A diagram of post-Fordist life, value and labor
Clinical Labor offers detailed insights of how clinical trials, ART and regenerative
medicine unfold aggressively in an expansive global post-Fordist economy. In a way,
the argumentative structure of Clinical Labor resembles Eduardo Galeano’s famous
Open Veins of Latin America (Galeano 1998). Galeano’s book details the brutal colonial
history of Latin America, by reconstructing, chapter by chapter, each country’s proper
history of productive relations through the lenses of distinct commodities such as sugar
cane, coffee or silver. While each separate chapter provides a compelling “stand alone”
analysis, the true force of Galeano’s narrative unfolds only if these strands are articu-
lated in an overall argument, thus revealing the overarching structures and patterns of
political-economic domination that emerge as forceful and concerted system. Similarly,
Clinical Labor provides a series of differentiated analyses, organized in separate chapters,
that each deliver thorough analyses of different technologies (ART, clinical trials, etc.)
articulated within particular socio-economic and cultural contexts (the US, China, Eastern
Europe, etc.), thereby producing varied subjects (the oocyte vendor, the uninsured clinical
research volunteer, etc.) and different forms of clinical labor (reproductive, regenerative,
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experimental, etc.). This differential perspective in itself is a welcome contribution to the
state of knowledge in these thematic fields of scholarship. But akin to Open Veins, the full
extent of Cooper and Waldby’s argument lies in the theoretical perspective on clin-
ical labor as a general phenomenon and trajectory of the intertwined biopolitical
(re-)organization of relationships between biomedicine and the post-Fordist economy. If
one abstracts from the contingencies of particular technologies, certain biocapital
branches, or regional specificities, “clinical labor” emerges as a powerful concept and
forceful reality structuring the ways in which biomedical production, consumption and
innovation is grounded in the more or less coercive exploitation of a steadily expanding,
largely informal labor force.
Conversely, the book provides a systematic and throughout comparative perspective
on global clinical labor, thereby establishing knowledge beyond the single case study
prevalent in social studies of science, technology, and biomedicine. Throughout, Clin-
ical Labor examines jointly the technical-biological as well as the legal-contractual pre-
conditions of biomedical innovation and bioeconomic expansion. For sure, novel
biological and technological possibilities of intervention have provided the ground for
the various developments described in the book; but far from engaging in a techno-
centric explanation, Cooper and Waldby show that clinical labor does not only emerge
from technological advances as such, but gain traction through various socio-economic
and legal realignments, including a heavy deployment of “atavistic” principles of labor
law. In this regard, Clinical Labor engages in a critical legal analysis that is closely tied
to a critical analysis of bioethics. Analyzing the interrelationships between labor law
and bioethics through the lenses of their shared implicit contractualism, Cooper and
Waldby show, for instance, that “the principle of informed consent has historically
evolved in a complex, often overlapping, yet largely undocumented dialogue with […]
contractual consent” (p. 223, original emphasis). While the “historical mission” of bio-
ethics was to protect biomedical subjects from harm and exploitation, bioethics has,
perhaps unwittingly, helped to facilitate the consolidation of the informal clinical labor
market and its globalization. Methodologically engaging in a veritably immanent cri-
tique, Cooper and Waldby’s analysis of bioethics goes well beyond common critical ap-
praisals of bioethics that suggest, for instance, that bioethics was somehow “coopted”
by the biomedical-industrial complex (see Turner 2009, for a discussion). Such a per-
spective provides powerful means to comprehensively understand and critically exam-
ine the role of bioethics within the overall deployment of the bioeconomy. Hence,
Cooper and Waldby’s “clinical labor theory of value” does not so much resemble a self-
enclosed theory (with capital T), but rather amounts to an intriguing theoretical per-
spective and generative framework of analysis. As such it invites to make the clinical
labor perspective an integral part of the study of realignments of life sciences and polit-
ical economy, and the study of contemporary biopolitics more generally.
In order to do so, we might suggest some further analytical dimensions that would
complement and further substantiate the critical study of clinical labor relations beyond
that what Clinical Labor has already accomplished. In their analysis of the biopolitical
reorganization of life, labor and value, only little attention is paid to questions of resist-
ance and contestation at the level of clinical labor itself. Perhaps one could say that
while Cooper and Waldby’s critique of clinical labor involves a thorough critique of
(novel as well as sustained) forms of domination and exploitation, it falls short on the
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analysis of concrete power struggles. Here, further projects could benefit form, and in
turn perfectly complement, studies of biopolitics that explore struggles and negotia-
tions, as well as practices of subversion and contestation, at the micro- or meso-level of
organization (see for instance Epstein 2007; Raman and Tutton 2010). Further, and
closely related, there is the question of subjectivity. For sure, Clinical Labor excels in a
detailed and differentiated analysis of the various subjects of clinical labor, exploring
various subjects within the different subcategories of reproductive, experimental etc.
labor. What Cooper and Waldby provide is a detailed map of subject positions, that is
to say, structural positions coproduced within the global bioeconomy: subjects of and
subjected by clinical labor. This type of analysis could be complemented with a more
explicit focus on forms of subjectivation – that is to say, the concrete forms in which
individuals and groups relate to and thereby “subjectify” clinical labor relations. Such
an added double focus on contestation and subjectivation could shed new analytical
light on pressing biopolitical questions. Take for instance cases where patients demand
access to new experimental therapies, such as promising yet unproven stem cell treat-
ments. By consuming such experimental treatments – many of them deployed “out-
side” the established norms of Western biomedicine and thus proscribed by bioethicists
and regulators – these patients not only subvert bioethical norms, but also often par-
ticipate in the clinical development of these therapies (Bharadwaj 2013). Here, clinical
labor touches closely upon questions of biopolitical or “therapeutic citizenship”
(Rose and Novas 2005; Nguyen 2005; Epstein 2007; Wehling 2010), a relationship
that deserves further empirical as well as theoretical attention. It is also in these
frontiers that biopolitical struggles are fought over a new emancipatory “ethics of
the bio” (Bharadwaj 2013).
To conclude: Introducing "clinical labor” as an intriguing concept to explore hitherto
marginalized aspects of biomedical innovation and neoliberal biopolitics, Clinical Labor
is a welcome contribution to social studies of biomedicine. The book should concern
everyone interested in the articulation of life, value and labor in global (bio-)economies.
It provides detailed insights into the contemporary organization of the life sciences by
exploring salient fields such as artificial reproductive technologies and clinical trials in
global and truly intersectional perspective. In doing so, it implicitly suggests a frame-
work for further analysis. Critical studies of biomedicine would benefit from further
engaging with clinical labor, both empirically and conceptually.
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